Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes

NCT01549769 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped IDMC recommendation for safety concerns

Conditions

Renal Insufficiency, Chronic
Diabetes Mellitus, Type 2

Interventions

DRUG: Bardoxolone Methyl

Sponsor

Biogen